Tamsulosin binds selectively and competitively to postsynaptic α1-adrenoceptors, in particular to the subtypes α1A and α1D. It brings about relaxation of prostatic and urethral smooth muscle.


Each hard gelatin capsule contains:
Tamsulosin Hydrochloride USP 0.4 mg
(In Modified Release Form)

Indications for use

  • Lower urinary tract symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH).

Mode of administration

One capsule daily, to be taken after breakfast or the first meal of the day.
No dose adjustment is warranted in renal impairment. No dose adjustment is warranted in patients with mild to moderate hepatic insufficiency.
Paediatric population:
There is no relevant indication for use of this medicine product in children.
The safety and efficacy of tamsulosin in children < 18 years have not been established.
Method of administration:
For oral use
The capsules must be swallowed whole and should not be crunched or chewed as this interfaces with the modified release of the active ingredient.